Northbrook company's muscular dystrophy drug wins FDA approval – Chicago Tribune
Chicago Tribune |
Northbrook company’s muscular dystrophy drug wins FDA approval
Chicago Tribune Liam McNicholas, 12, of Lindenhurst, talks with Meghan Kostyk, an advanced practice nurse, on Feb. 9, 2017, during his biannual visit to Lurie Children’s Hospital for a checkup. Liam has Duchenne muscular dystrophy, a condition which is treated by a … FDA approves drug to treat Duchenne muscular dystrophy MDA Celebrates News of FDA Approval of Emflaza for Treatment of Duchenne Muscular Dystrophy FDA Clears Deflazacort (Emflaza) for DMD |
View original article
Author:
Powered by WPeMatico
Health Topic Contributor
Editors and curators bringing you the latest and most impactful health news. Truly objective, we print links to stories and studies that may contradict one another. If you're searching for news on health studies, alternative health modalities, facts on modern allopathic medicine, and more, we're you're team bringing you the stories and facts that matter.